BioHealth News
Rich Bendis to Discuss U.S. Capital Region’s Role in APEC Dialogue on Medical Product Supply Chain on April 25th at USP
BioHealth Innovation is proud to announce that Rich Bendis, Founder and CEO, will be participating in the upcoming…
Read MoreMason engineers and partners receive $3M award to build new technology for personalized musculoskeletal injury rehabilitation to support troop readiness
April 20, 2023 / By Katie Maney Musculoskeletal injury (MSKI) is the most common form of medical injury experienced by Service members. Clinical interventions…
Read MoreGain Therapeutics Revolutionary Drug Discovery: Combining Physics, Biochemistry, and Supercomputing
Discovering treatments for patients that currently have no available disease-modifying options is the priority of Gain Therapeutics. Specifically, there is a large unmet need…
Read MoreMaryland General Assembly passes legislation to create TEDCO Equitech fund – BizJournals
By Matt Hooke - Reporter April 20, 2023, 03:04pm EDT The Maryland General Assembly passed a bill that would establish a Maryland Technology Development Corp.…
Read MoreMaryland Tech Council Announces 2023 ICON Awards Finalists
Winners will be revealed at the celebration on April 27th The Maryland Tech Council (MTC) is proud to announce the ICON awards finalists for…
Read MoreUSP to Host the 2023 BioHealth Capital Region Forum, Investment Conference, & Crab Trap Competition on September 19, 20 & 21
BioHealth Innovation, Inc. (BHI) is proud to announce that US Pharmacopeia (USP) will be hosting the 9th Annual BioHealth Capital Region Forum for the…
Read MoreGreater Rockville Chamber of Commerce CEO named 2023 Maryland Chamber Executive of the year
The Greater Rockville Chamber of Commerce’s Chief Executive Officer, Marji Graf, serves on Rockville Economic Development, Inc’s (REDI) Board of Directors. REDI congratulates GRCC…
Read MoreMaryland Industrial Partnerships (MIPS) – Proposals are due May 1!
Proposals are due May 1! Grants for Technology Product Development Market-driven new technology and innovation leads to new products and new jobs. Creating jobs…
Read MoreGermantown’s Deka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of Cancer Treatment – The MoCo Show
Deka Biosciences (“Deka”), a clinical-stage biotechnology company headquartered at 20271 Goldenrod Lane in Germantown and focused on developing novel cytokine therapies to treat cancer…
Read MoreTRUiC: 19 Best Angel Investor Groups for Startups
Angel investors are a great way to obtain startup funding for your business. Typically, angel investors for startups fund early and seed-stage companies that show promise for…
Read MoreMontgomery County Economic Development Corporation Adds New Board Members
April 12, 2023 Joining Experienced Business Executives Across Industries, Education and Government to Enhance Economic Development in Montgomery County Rockville, MD — Under the…
Read MoreBioBuzz: Here Are Several BioHealth Capital Region Life Science Companies Hiring Right Now: Q2 2023
By Alex KeownApril 13, 2023 Companies within the BioHealth Capital Region hub are hiring for multiple positions in Maryland, Virginia and Washington, D.C. BioBuzz rounds…
Read MoreCharlotte’s Tanner Pharma Group and Rockville’s ExeGi Pharma Announce Partnership to Distribute High Potency Probiotic
Partnership Announced to Distribute High Potency Probiotic in Mexico to Support Patients with Gut Microbiome Imbalance Rockville, M.D., and Charlotte, N.C., April 12, 2023…
Read MoreAltimmune Completes Enrollment In Phase 2 Clinical Trial Of HepTcell™, An Immunotherapeutic For Chronic Hepatitis B
April 11, 2023 at 7:30 AM EDT GAITHERSBURG, Md., April 11, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company (the Company), today announced that…
Read MoreREGENXBIO Receives FDA Fast Track Designation for RGX-202, a Novel Gene Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy
RGX-202 is a potential one-time AAV Therapeutic for the treatment of Duchenne and includes an optimized transgene for a novel microdystrophin and REGENXBIO's proprietary…
Read More